Gender and race/ethnicity differences in lead dose biomarkers

American Journal of Public Health

Volumn 98, Issue 7, 2008, Pages 1248-1255

  Theppeang, Keson ^a   Glass, Thomas A ^a   Bandeen Roche, Karen ^a   Todd, Andrew C ^b   Rohde, Charles A ^a   Schwartz, Brian S ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CADMIUM 109; LEAD; APOLIPOPROTEIN E4;

ADULT; AFRICAN AMERICAN; AGED; AGING; ANODIC STRIPPING POTENTIOMETRY; ARTICLE; BONE DEMINERALIZATION; BONE LEVEL; ETHNIC DIFFERENCE; GENOTYPE; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; PATELLA; PHYSICAL ACTIVITY; RACE DIFFERENCE; SEX DIFFERENCE; TIBIA; TOXICOKINETICS; UNITED STATES; BLOOD; CAUCASIAN; CHEMISTRY; COGNITIVE DEFECT; COMPARATIVE STUDY; ENVIRONMENTAL EXPOSURE; ETHNOLOGY; FEMALE; MALE; METABOLISM; METHODOLOGY; PREDICTION AND FORECASTING; SEX RATIO; SOCIOECONOMICS; SPECTROMETRY; STATISTICS;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN E4; BALTIMORE; COGNITION DISORDERS; ENVIRONMENTAL EXPOSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LEAD; LEAD POISONING, NERVOUS SYSTEM, ADULT; MALE; PATELLA; PREDICTIVE VALUE OF TESTS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; SPECTROMETRY, X-RAY EMISSION; TIBIA;

EID: 45549087296     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.118505     Document Type: Article

References (68)

1. Needleman HL. The removal of lead from gasoline: historical and personal reflections. Environ Res. 2000;84:20-35.
2. Pirkle JL, Brody DJ, Gunter EW, et al. The decline in blood lead levels in the United States: the National Health and Nutrition Examination Surveys (NHANES). JAMA. 1994;272:284-291.
3. Tepper LB, Levin LS. A survey of air and population lead levels in selected American communities. Environ Qual Saf Suppl. 1975;2:152-196.
4. Rabinowitz MB, Wetherill GW, Kopple JD. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest. 1976;58:260-270.
5. Links JM, Schwartz BS, Simon D, Bandeen-Roche K, Stewart WF. Characterization of toxicokinetics and toxicodynamics with linear systems theory: application to lead-associated cognitive decline. Environ Health Perspect. 2001;109:361-368.
6. Kim R, Landrigan C, Mossmann P, Sparrow D, Hu H. Age and secular trends in bone lead levels in middle-aged and elderly men: three-year longitudinal follow-up in the Normative Aging Study. Am J Epidemiol. 1997;146:586-591.
7. Chettle D. Advances in X-ray Analysis, Volume 38. New York, NY: Plenum Press; 1995.
8. Todd AC, Chettle DR. In vivo X-ray fluorescence of lead in bone: review and current issues. Environ Health Perspect.1994;102:172-177.
9. Rosen JF. The metabolism of lead in isolated bone cell populations: interactions between lead and calcium. Toxicol Appl Pharmacol. 1983;71:101-112.
10. Gerhardsson L, Attewell R, Chettle DR, et al. In vivo measurements of lead in bone in long-term exposed lead smelter workers. Arch Environ Health. 1993;48:147-156.
11. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res.1988;47:79-94.
12. Fullmer CS. Intestinal interactions of lead and calcium. Neurotoxicology. 1992;13:799-807.
13. Smith DR, Osterloh JD, Flegal AR. Use of endogenous, stable lead isotopes to determine release of lead from the skeleton. Environ Health Perspect. 1996;104:60-66.
14. Symanski E, Hertz-Picciotto I. Blood lead levels in relation to menopause, smoking, and pregnancy history. Am J Epidemiol. 1995;141:1047-1058.
15. Christoffersson JO, Schütz A, Ahlgren L, Haeger-Aronsen B, Mattsson S, Skerfving S. Lead in finger-bone analysed in vivo in active and retired lead workers. Am J Ind Med.1984;6:447-457.
16. Vig EK, Hu H. Lead toxicity in older adults. J Am Geriatr Soc. 2000;48:1501-1506.
17. Kosnett MJ, Becker CE, Osterloh JD, Kelly TJ, Pasta DJ. Factors influencing bone lead concentration in a suburban community assessed by noninvasive K x-ray fluorescence. JAMA. 1994;271:197-203.
18. Hernandez-Avila M, Gonzalez-Cossio T, Palazuelos E, et al. Dietary and environmental determinants of blood and bone lead levels in lactating postpartum women living in Mexico City. Environ Health Perspect.1996;104:1076-1082.
19. Brown MJ, Hu H, Gonzales-Cossio T, et al. Determinants of bone and blood lead concentrations in the early postpartum period. Occup Environ Med. 2000;57:535-541.
20. Farias P, Echavarria M, Hernandez-Avila M, et al. Bone, blood and semen lead in men with environmental and moderate occupational exposure. Int J Environ Health Res. 2005;15:21-31.
21. Hu H, Payton M, Korrick S, et al. Determinants of bone and blood lead levels among community-exposed middle-aged to elderly men. The normative aging study. Am J Epidemiol. 1996;144:749-759.
22. Hoppin JA, Aro A, Hu H, Ryan PB. In vivo bone lead measurement in suburban teenagers. Pediatrics. 1997;100(3 Pt 1):365-370.
23. Elreedy S, Krieger N, Ryan PB, Sparrow D, Weiss ST, Hu H. Relations between individual and neighborhood-based measures of socioeconomic position and bone lead concentrations among community-exposed men: the Normative Aging Study. Am J Epidemiol. 1999;150:129-141.
24. Hu H, Wu MT, Cheng Y, Sparrow D, Weiss S, Kelsey K. The delta-aminolevulinic acid dehydratase (ALAD) polymorphism and bone and blood lead levels in community-exposed men: the Normative Aging Study. Environ Health Perspect. 2001;109:827-832.
25. Elmarsafawy SF, Tsaih SW, Korrick S, et al. Occupational determinants of bone and blood lead levels in middle aged and elderly men from the general community: the Normative Aging Study. Am J Ind Med. 2002;42:38-49.
26. Korrick SA, Schwartz J, Tsaih SW, et al. Correlates of bone and blood lead levels among middle-aged and elderly women. Am J Epidemiol. 2002;156:335-343.
27. Lin C, Kim R, Tsaih SW, Sparrow D, Hu H. Determinants of bone and blood lead levels among minorities living in the Boston area. Environ Health Perspect. 2004;112:1147-1151.
28. Lanphear BP, Weitzman M, Eberly S. Racial differences in Urban children's environmental exposures to lead. Am J Public Health. 1996;86:1460-1463.
29. Brody DJ, Pirkle JL, Kramer RA, et al. Blood lead levels in the US population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA. 1994;272:277-283.
30. Bailey AJ, Sargent JD, Goodman DC, Freeman J, Brown MJ. Poisoned landscapes: the epidemiology of environmental lead exposure in Massachusetts children 1990-1991. Soc Sci Med. 1994;39:757-766.
31. Alexander DL. Chronic lead exposure: a problem for minority workers. AAOHN J. 1989;37:105-108.
32. Tong S, von Schirnding YE, Prapamontol T. Environmental lead exposure: a public health problem of global dimensions. Bull World Health Organ. 2000;78:1068-1077.
33. Schwartz BS, Glass TA, Bolla KI, et al. Disparities in cognitive functioning by race/ethnicity in the Baltimore Memory Study. Environ Health Perspect. 2004;112:314-320.
34. Chettle DR, Scott MC, Somervaille LJ. Lead in bone: sampling and quantitation using K X-rays excited by 109Cd. Environ Health Perspect. 1991;91:49-55.
35. Todd AC, McNeill FE. In vivo measurements of lead in bone using a 109Cd "spot" source. In: Ellis KJ, Eastman JD, eds. Human Body Composition Studies. New York, NY: Plenum Press; 1993:299-302.
36. Wetmur JG, Lehnert G, Desnick RJ. The delta-aminolevulinate dehydratase polymorphism: higher blood lead levels in lead workers and environmentally exposed children with the 1-2 and 2-2 isozymes. Environ Res. 1991;56:109-119.
37. Schwartz BS, Lee BK, Lee GS, et al. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2000;108:949-954.
38. Chuang HY, Schwartz J, Tsai SY, Lee ML, Wang JD, Hu H. Vibration perception thresholds in workers with long term exposure to lead. Occup Environ Med. 2000;57:588-594.
39. Audi L, Garcia-Ramirez M, Carrascosa A. Genetic determinants of bone mass. Horm Res. 1999;51:105-123.
40. Zmuda JM, Cauley JA, Ferrell RE. Recent progress in understanding the genetic susceptibility to osteoporosis. Genet Epidemiol. 1999;16:356-367.
41. Stewart WF, Schwartz BS, Simon D, Kelsey K, Todd AC. ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ Health Perspect. 2002;110:501-505.
42. Schafer JH, Glass TA, Bolla KI, Mintz M, Jedlicka AE, Schwartz BS. Homocysteine and cognitive function in a population-based study of older adults. J Am Geriatr Soc. 2005;53:381-388.
43. Dipietro L, Caspersen CJ, Ostfeld AM, Nadel ER. A survey for assessing physical activity among older adults. Med Sci Sports Exerc. 1993;25:628-642.
44. Kim R, Aro A, Rotnitzky A, Amarasiriwardena C, Hu H. K x-ray fluorescence measurements of bone lead concentration: the analysis of low-level data. Phys Med Biol. 1995;40:1475-1485.
45. Austin PC, Escobar M, Kopec JA. The use of the Tobit model for analyzing measures of health status. Qual Life Res. 2000;9:901-910.
46. Pindyck RS, Rubinfeld DL. Econometric Models and Economic Forecasts. 4th ed. Boston, MA: Irwin/ McGraw-Hill; 1998.
47. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
48. Huang GH, Bandeen-Roche K, Rubin GS. Building marginal models for multiple ordinal measurements. Appl Stat. 2002;51:1-21.
49. Veall MR, Zimmermann KF. Goodness of fit measures in the Tobit model. Oxf Bull Econ Stat. 1994;56:485-499.
50. Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998;106:1-8.
51. Marcus R, Feldman D, Kelsey JL. Osteoporosis. San Diego, CA: Academic Press; 1996.
52. Rabinowitz MB. Toxicokinetics of bone lead. Environ Health Perspect. 1991;91:33-37.
53. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. World Health Organization Study Group. Osteoporos Int. 1994;4:368-381.
54. Schwartz BS, Stewart WF, Kelsey KT, et al. Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers. Environ Health Perspect. 2000;108:199-203.
55. Shiraki M, Shiraki Y, Aoki C, et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res. 1997;12:1438-1445.
56. Annest JL, Pirkle JL, Makuc D, Neese JW, Bayse DD, Kovar MG. Chronological trend in blood lead levels between 1976 and 1980. N Engl J Med. 1983;308:1373-1377.
57. Pirkle JL, Kaufmann RB, Brody DJ, Hickman T, Gunter EW, Paschal DC. Exposure of the U.S. population to lead, 1991-1994. Environ Health Perspect. 1998;106:745-750.
58. Shih RA, Glass TA, Bandeen-Roche K, et al. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology. 2006;67:1556-1562.
59. Weisskopf MG, Wright RO, Schwartz J, et al. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol. 2004;160:1184-1193.
60. Glenn BS, Bandeen-Roche K, Lee BK, Weaver VM, Todd AC, Schwartz BS. Changes in systolic blood pressure associated with lead in blood and bone. Epidemiology. 2006;17:538-544.
61. Lee BK, Lee GS, Stewart WF, et al. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect. 2001;109:383-389.
62. Lin JL, Lin-Tan DT, Li YJ, Chen KH, Huang YL. Low-level environmental exposure to lead and progressive chronic kidney diseases. Am J Med. 2006;119:707.e1-707.e9.
63. Weaver VM, Jaar BG, Schwartz BS, et al. Associations among lead dose biomarkers, uric acid, and renal function in Korean lead workers. Environ Health Perspect. 2005;113:36-42.
64. Weiss B, Bellinger DC. Social ecology of children's vulnerability to environmental pollutants. Environ Health Perspect. 2006;114:1479-1485.
65. Martin D, Glass TA, Bandeen-Roche K, Todd AC, Shi W, Schwartz BS. Association of blood lead and tibia lead with blood pressure and hypertension in a community sample of older adults. Am J Epidemiol. 2006;163:467-478.
66. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337-1342.
67. Kawas CH, Brookmeyer R. Aging and the public health effects of dementia. N Engl J Med. 2001;344:1160-1161.
68. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3:186-191.